immuno-oncology

Immuno-Oncology 2018 News: MHRA Interview and New Speaker ImmuneBiotech AB Announced

Just Over 1 Week Until Immuno-Oncology 2018 Commences

Immuno-Oncology 2018 News: MHRA Interview and New Speaker ImmuneBiotech AB Announced

https://pharmaphorum.com/partner-content/immuno-oncology-2018-news-mhra-interview-and-new-speaker-immunebiotech-ab-announced/

MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immuno-Oncology Conference

MHRA, Pfizer & Autolus Sign Up for Immuno-Oncology 2018

MHRA, Pfizer, Autolus and Tusk Theraputics Sign Up for Immuno-Oncology Conference

https://pharmaphorum.com/partner-content/mhra-pfizer-autolus-and-tusk-theraputics-sign-up-for-immuno-oncology-conference/

Less than 4 Weeks until Immuno-Therapy Experts Gather at the Immuno-Oncology Conference

Less than 4 Weeks until Immuno-Oncology Conference

Less than 4 Weeks until Immuno-Therapy Experts Gather at the Immuno-Oncology Conference

https://pharmaphorum.com/partner-content/less-than-4-weeks-until-immuno-therapy-experts-gather-at-the-immuno-oncology-conference/

Invitation from Chair of this year’s Immuno-Oncology Conference in London

Invitation from Chair of Immuno-Oncology Conference

Invitation from Chair of this year’s Immuno-Oncology Conference in London

https://pharmaphorum.com/partner-content/invitation-from-chair-of-this-years-immuno-oncology-conference-in-london/

Immuno-Oncology challenges include identifying patients before therapy, limited responses and biomarker research

Challenges facing Immuno-Oncology industry

Immuno-Oncology challenges include identifying patients before therapy, limited responses and biomarker research

https://pharmaphorum.com/partner-content/immuno-oncology-challenges-include-identifying-patients-before-therapy-limited-responses-and-biomarker-research/

Strategic Competitive Intelligence and the role of the Microbiome in Immuno-Oncology

Immuno-Oncology Conference – London – September

Strategic Competitive Intelligence and the role of the Microbiome in Immuno-Oncology

https://pharmaphorum.com/partner-content/strategic-competitive-intelligence-and-the-role-of-the-microbiome-in-immuno-oncology/

Updates on Keytruda and future potential therapies advancements in Immuno-Oncology

SMi Group reports on preparations for SMi’s inaugural Immuno-Oncology Conference, which is scheduled to take place 26 –

Updates on Keytruda and future potential therapies advancements in Immuno-Oncology

https://pharmaphorum.com/partner-content/updates-on-keytruda-and-future-potential-therapies-advancements-in-immuno-oncology/

BMS strikes back with lung cancer combo success

Just as it looked like Bristol Myers Squibb might never catch up with its rivals in frontline lung cancer treatment, the company has achieved success in a new combination.

BMS strikes back with lung cancer combo success

https://pharmaphorum.com/news/bms-strikes-back-lung-cancer-combo-success/

Merck’s Keytruda fails in gastric cancer trial

Trial missed overall survival endpoint

Merck’s Keytruda fails in gastric cancer trial

https://pharmaphorum.com/news/mercks-keytruda-fails-gastric-cancer-trial/

1 2 3 4 5

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

immuno-oncology